 Home > Active Ingredient News > Blood System > J Clin Oncol: Announcement of the long-term safety and effectiveness of multi-drug chemotherapy for newly diagnosed pediatric T lymphocytic lymphoma (COG AALL0434 study)

J Clin Oncol: Announcement of the long-term safety and effectiveness of multi-drug chemotherapy for newly diagnosed pediatric T lymphocytic lymphoma (COG AALL0434 study)

 Last Update: 2021-08-03
 Source: Internet
 Author: User

Tags

high person

high quality scissors

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

The COG AALL0434 program evaluated the safety and effectiveness of multi-drug chemotherapy based on Capizzi-based methotrexate/baconase (C-MTX) in patients with newly diagnosed pediatric T-cell lymphoma (T-LL), and obtained Preliminary data on the use of Nelarabine in high-risk patients

Leave a message here

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

GUANFACINE HCL Factory Price Pharmaceutical Chemical Purity Degree 99%

CAS No.: 29110-48-3

Pharmacy Grade

$10-13/G FOB

Ticlopidine

CAS No.: 55142-85-3

$1/KG EXW

4-(Aminomethyl)benzoic acid

CAS No.: 56-91-7

$1/KG EXW

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

announcements today(81)

80 20 company(94)

united states logo(227)

single use technology(195)

healthy food name(42)

ups united states(221)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.